Shattuck Labs (STTK) Cash & Equivalents (2019 - 2026)

Shattuck Labs (STTK) has reported Cash & Equivalents for 8 consecutive years, with $90.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 48.48% year-over-year to $90.4 million; the TTM figure through Mar 2026 stood at $90.4 million (up 48.48% YoY), while the FY2025 annual figure was $54.2 million, down 5.57% from the prior year.
• Cash & Equivalents grew to $90.4 million in Q1 2026 per STTK's latest filing, from $54.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $125.6 million in Q4 2023 and bottomed at $37.9 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $59.8 million across 5 years, with a median of $54.2 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 56.22% — and 2023, when it surged 165.15%.
• Shattuck Labs' Cash & Equivalents stood at $47.4 million in 2022, then soared by 165.15% to $125.6 million in 2023, then tumbled by 54.32% to $57.4 million in 2024, then fell by 5.57% to $54.2 million in 2025, then surged by 66.85% to $90.4 million in 2026.
• Business Quant data shows STTK's Cash & Equivalents at $90.4 million in Q1 2026, $54.2 million in Q4 2025, and $42.5 million in Q3 2025.